Viscoelastic fluids are key to the most basic of human functions. From tears to the fluid in your joints, appropriate fluid characteristics are directly tied to proper tissue performance. The viscoelastic market has been largely reliant on single ingredient compositions for decades, and Arthrodynamic Holdings, LLC is positioned to raise the bar by which viscoelastics are judged. We have developed a comprehensive viscoelastic, termed ADH-01, that combines three essential components for multiple medical applications.
The composition consists of the key building blocks in synovial fluid and cartilage, being hyaluronic acid, chondroitin sulfate, and n-acetyl-d-glucosamine.
ADH's technology was originally commercialized for veterinary orthopedics., and is now one of the leading joint viscoelastics in animal health.
The first application is as a combination product for orthopedic applications, with follow-on applications in urology and other tissue repair areas.
Our composition is made to high purity, meeting the requirements for Good Manufacturing Practices.
We have developed a novel, patented viscoelastic composition for various medical applications.
Knee Osteoarthritis (lead indication) Existing Viscoelastic Market Hyaluronic acid injections (i.e. visco-supplementation) are considered a first-line treatment for osteoarthritis. Some estimates value the current market in excess of $3 billion USD. Given the aging population, combined with…
Read More
Interstitial cystitis is a urological condition, resulting in inflammation of the bladder wall. The causes of interstitial cystitis (IC) are poorly understood and may be multifactoral in nature. IC can result in bladder pain, a feeling of…
Read More
Regenerative medicine using cells is highly reliant on the ability to grow and expand cells outside the body (ex vivo). Researchers are constantly trying to improve the conditions by which cells are grown, expanded and stored to…
Read More